Skip to record
ExecutivesEric Bjerkholt

Executive record

Eric Bjerkholt

Director at Surrozen, Inc./DE

Follow record
More
Challenge a Claim

Alpha ID: alpha:person:eric-bjerkholtVersion: public-0As of: 2026-10-01

Not yet claimed9 published Claims3 sources
  • Director

Leadership, in context.

Connect capital, control, accountability, and evidence.

Published Claims9Within this recordEvidence sources3Inspect provenance and dates

Explore the record

ResponsibilitiesInspect board appointments and committee mandates.ExperienceReview career history and qualifications in context.Economic interestsExamine disclosed incentives and ownership.

Key Claims

Biography

Mr. Bjerkholt has served as CFO of Mirum Pharmaceuticals since September 2023, overseeing legal, financial reporting, budgeting, internal controls, investor relations, facilities and IT. He previously served as CFO of Chinook Therapeutics and Aimmune Therapeutics. He spent 13 years at Sunesis Pharmaceuticals in various executive roles and has 7 years of healthcare investment banking experience at J.P. Morgan.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.